Literature DB >> 30263350

Extract of Makgeolli suldeot downregulates NF-κB-mediated MMP-9 expression, thereby inhibiting invasive activity in a human breast cancer cell line, MDA-MB-231.

Sang-Jin Lee1, Sunyoung Park2,3, Gyu-Un Bae1, Hye Yoon Park4, Changmu Kim4, Cheon-Seok Park2, Gye-Won Kim5.   

Abstract

Makgeolli is a Korean traditional alcoholic beverage prepared by fermenting rice starch using nuruk. It is known for its health benefits, but the mechanisms underlying its inhibitory effects on cancer remain unclear. Here a 70% ethanol extract of Makgeolli suldeot (70EMS) was tested for its inhibitory activities against cancer metastasis. This extract interrupted the formation of the neovasculature and reduced the migratory and invasive activity of breast cancer cells. Furthermore, it dose-dependently suppressed the activity of matrix metalloproteinase (MMP)-9 and phosphorylation of ERK1/2, JNK, and Akt. Moreover, 70EMS strongly inhibited the translocation of nuclear factor-kappa B (NF-κB) into the nucleus and expression of activator protein-1 (AP-1). These data indicate that the anti-invasive effect of 70EMS may be related to the inhibition of ERK1/2, phosphorylation of JNK, and reduced expression of NF-κB and AP-1, thereby attenuating MMP-9 in human breast cancer cells.

Entities:  

Keywords:  anti-invasion; breast cancer; makgeolli suldeot; matrix metalloproteinase-9; nuclear factor-kappa B

Year:  2016        PMID: 30263350      PMCID: PMC6049157          DOI: 10.1007/s10068-016-0146-z

Source DB:  PubMed          Journal:  Food Sci Biotechnol        ISSN: 1226-7708            Impact factor:   2.391


  19 in total

1.  Regulation of 92 kDa type IV collagenase expression by the jun aminoterminal kinase- and the extracellular signal-regulated kinase-dependent signaling cascades.

Authors:  R Gum; H Wang; E Lengyel; J Juarez; D Boyd
Journal:  Oncogene       Date:  1997-03-27       Impact factor: 9.867

2.  Src kinase regulates metalloproteinase-9 secretion induced by type IV collagen in MCF-7 human breast cancer cells.

Authors:  Pedro Cortes-Reynosa; Teresa Robledo; Marina Macias-Silva; S Vincent Wu; Eduardo Perez Salazar
Journal:  Matrix Biol       Date:  2007-11-12       Impact factor: 11.583

Review 3.  Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis.

Authors:  D Hanahan; J Folkman
Journal:  Cell       Date:  1996-08-09       Impact factor: 41.582

Review 4.  Matrix metalloproteinases and tumor metastasis.

Authors:  Elena I Deryugina; James P Quigley
Journal:  Cancer Metastasis Rev       Date:  2006-03       Impact factor: 9.264

Review 5.  NF-kappaB: linking inflammation and immunity to cancer development and progression.

Authors:  Michael Karin; Florian R Greten
Journal:  Nat Rev Immunol       Date:  2005-10       Impact factor: 53.106

Review 6.  Gelatinase-mediated migration and invasion of cancer cells.

Authors:  Mikael Björklund; Erkki Koivunen
Journal:  Biochim Biophys Acta       Date:  2005-04-12

7.  Amplification of IL-1 beta-induced matrix metalloproteinase-9 expression by superoxide in rat glomerular mesangial cells is mediated by increased activities of NF-kappa B and activating protein-1 and involves activation of the mitogen-activated protein kinase pathways.

Authors:  W Eberhardt; A Huwiler; K F Beck; S Walpen; J Pfeilschifter
Journal:  J Immunol       Date:  2000-11-15       Impact factor: 5.422

8.  The RhoA pathway mediates MMP-2 and MMP-9-independent invasive behavior in a triple-negative breast cancer cell line.

Authors:  Katerina D Fagan-Solis; Sallie Smith Schneider; Brian T Pentecost; Brook A Bentley; Christopher N Otis; John F Gierthy; Kathleen F Arcaro
Journal:  J Cell Biochem       Date:  2013-06       Impact factor: 4.429

Review 9.  MAP kinase signalling pathways in cancer.

Authors:  A S Dhillon; S Hagan; O Rath; W Kolch
Journal:  Oncogene       Date:  2007-05-14       Impact factor: 9.867

10.  Suppression of PMA-induced tumor cell invasion by capillarisin via the inhibition of NF-kappaB-dependent MMP-9 expression.

Authors:  Syng-Ook Lee; Yun-Jeong Jeong; Mihyun Kim; Cheorl-Ho Kim; In-Seon Lee
Journal:  Biochem Biophys Res Commun       Date:  2007-12-26       Impact factor: 3.575

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.